SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-19-012285
Filing Date
2019-06-19
Accepted
2019-06-19 16:30:50
Documents
2
Period of Report
2019-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3662
2 poa-randall.htm EX-24 6972
  Complete submission text file 0001437749-19-012285.txt   12280
Mailing Address C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Business Address C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ 508-481-4648
RANDALL PATRICIA (Reporting) CIK: 0001272779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36200 | Film No.: 19906365

Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Issuer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances